Vaxart Welcomes Raquel C. Bono to Board with Initial Form 3
Vaxart, Inc.
Subscribe to track VXRT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Vaxart Welcomes Raquel C. Bono to Board with Initial Form 3
Company: Vaxart, Inc. (VXRT) Form: 3 | Filed: 2026-10-20 Significance: Low
Insider: Raquel C. Bono Title: Director | Relationship: Director
Holdings: • Direct/Indirect Shares: 0 • Securities Owned: None reported
Key Insight: Initial statement of beneficial ownership following appointment to the Board of Directors, showing no current equity holdings.
Market Context: Routine Section 16 compliance filing for micro-cap biotech Vaxart ($110M market cap).
Comprehensive Analysis
SEC Filing Analysis: Vaxart, Inc. (VXRT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Raquel C. Bono filed an initial Form 3 following appointment to the Board of Directors, reporting no initial beneficial ownership of company securities.
- Market Impact: Neutral; routine administrative compliance filing with zero immediate market or dilution impact.
Company Information
| Field | Value |
|---|---|
| Company | Vaxart, Inc. |
| Ticker Symbol | VXRT |
| CIK | 0000072444 |
| Industry | Biological Products (No Diagnostic Substances) |
Insider Information
| Field | Value |
|---|---|
| Name | Raquel C. Bono |
| CIK | 0001823759 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 3 |
| Event Date | 2026-10-16 |
| Securities Owned | 0 |
| Transaction Type | Initial Statement (No Securities Owned) |
Financial Impact Assessment
Transaction Materiality
- Shares Owned: 0 shares (0.00% of 241.97M shares outstanding)
- Market Cap Context: With Vaxart's market capitalization at approximately $110 million, this initial filing creates zero capital impact or dilution.
- Materiality Assessment: Low. As an initial Form 3 filing disclosing zero shares owned, there is no direct financial transaction or ownership change.
Market Impact Analysis
- Stock Impact Direction: Neutral
- Reasoning: Initial ownership disclosures with zero shares are standard Section 16 procedural filings upon joining a corporate board.
- Volume & Sentiment: No effect expected on trading volume or overall investor sentiment.
Additional Context
- Transaction Notes: Accompanying Exhibit 24 provides a Limited Power of Attorney for Section 16 filings executed on October 12, 2026.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.